Both genetic (Cho 2008) and functional studies (Xavier and Podolsky 2007) support a role for STAT3 in IBD; indeed, STAT3 is a proposed IBD therapeutic target (Lee et al. 2015; Nguyen et al. 2015). The gene discussed is STAT3; the disease is inflammatory bowel disease.